[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600653":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":53,"collaborators":10,"id":57,"slug":10,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":10,"enrollmentInfo":65,"targetDuration":68,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Complejo Hospitalario Universitario Insular Materno Infantil","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"ovarian cancer patients",null,[12],"Other: resection of infundibulopelvic ligament",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":10},"resection of infundibulopelvic ligament","Therefore, this study also aims to perform bilateral infundibulopelvic ligament resection (at least 8 cm in length) during surgery for ovarian cancer patients",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"beatriz NAVARRO SANTANA, pHD","CONTACT","+34620151146","bea_0904@hotmail.com",[25],{"facility":26,"status":27,"city":28,"state":10,"zip":10,"country":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Complejo Universitario Insular Materno Infantil de Las Palmas","RECRUITING","Las Palmas de Gran Canaria","Spain",{"type":31,"coordinates":32},"Point",[33,34],-15.41573,28.10178,{"lat":34,"lon":33},[37,41,42,45,47,49,51],{"name":38,"role":21,"phone":39,"phoneExt":10,"email":40},"Alicia Martin Martinez, phd","+34649088104","aliciammartinez@gmail.com",{"name":10,"role":21,"phone":10,"phoneExt":10,"email":23},{"name":43,"role":44,"phone":10,"phoneExt":10,"email":10},"Octavio Arencibia Sanchez, MD","SUB_INVESTIGATOR",{"name":46,"role":44,"phone":10,"phoneExt":10,"email":10},"DANIEL GONZALEZ, MD",{"name":48,"role":44,"phone":10,"phoneExt":10,"email":10},"Andres Rave, MD",{"name":50,"role":44,"phone":10,"phoneExt":10,"email":10},"Jesus Guijarro, MD",{"name":52,"role":44,"phone":10,"phoneExt":10,"email":10},"Alicia Martín Martínez, MD",{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Beatriz Fatima Navarro Santana","GYNECOLOGIST ONCOLOGIST","100600653",false,"NCT07100288","Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer","INFPELV","Inclusion Criteria:\n\n* ◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.\n\n  * FIGO 2014 stage IA-IVB.\n  * Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy\n  * Patients with no residual disease after surgery.\n  * Patients with ECOG performance status 0-1.\n\nExclusion Criteria:\n\n* ◦ Patients without epithelial ovarian cancer.\n\n  * Patients with ECOG 2-4.\n  * Patients who do not consent to participate in the study.\n  * Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.","FEMALE","18 Years",{"count":66,"type":67},200,"ESTIMATED","2 Years","OBSERVATIONAL","Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis",[72,73,74],"Ovarian Cancer","Ovarian Cancer (OvCa)","Ovarian Adenocarcinoma","2025-07-27",{"date":77,"type":78},"2025-08-03","ACTUAL",{"date":80,"type":78},"2025-07-20",{"date":82,"type":67},"2030-12-30",{"name":5,"class":6},1]